Explain how the structure of an antibody enables it to neutralise a specific pathogen.
Written & reviewed by James Millett — Biology (Imperial College London), PGCE Science (University of Cambridge).
Model answer (4 marks)
Antibodies contain a variable (hypervariable) region that folds into a specific tertiary structure forming the antigen‑binding site. This site is complementary in shape and charge to a particular epitope on a pathogen’s surface antigen, allowing binding through non‑covalent interactions.
Each antibody is Y‑shaped and has two identical antigen‑binding sites, so one antibody can bind two antigens. This bivalency enables cross‑linking of pathogens, leading to agglutination.
The constant (Fc) region of the antibody can bind to receptors on phagocytes, acting as an opsonin. Opsonisation together with agglutination prevents the pathogen from infecting host cells and facilitates its removal, thereby neutralising the pathogen.
Each antibody is Y‑shaped and has two identical antigen‑binding sites, so one antibody can bind two antigens. This bivalency enables cross‑linking of pathogens, leading to agglutination.
The constant (Fc) region of the antibody can bind to receptors on phagocytes, acting as an opsonin. Opsonisation together with agglutination prevents the pathogen from infecting host cells and facilitates its removal, thereby neutralising the pathogen.
Examiner tips
- Show the variable region and its role in specificity; mention the Y‑shape and two binding sites; link agglutination and opsonisation to neutralisation; use correct terminology (hypervariable, epitope, Fc).
Common mistakes
- Confusing the variable region with the constant region; forgetting that antibodies have two identical binding sites; not linking agglutination/opsonisation to neutralisation; using vague terms like "binding" without specifying non‑covalent interactions.
Mark scheme (4 marks)
- Antibodies have a variable region (hypervariable region) with a specific tertiary structure / shape that forms the antigen-binding site
- The antigen-binding site is complementary to a specific epitope on the pathogen's surface antigen, allowing binding by non-covalent interactions
- Each antibody molecule has two identical antigen-binding sites (Y-shaped / bivalent structure), enabling cross-linking / agglutination of pathogens into clumps
- Agglutination / opsonisation (via the constant/Fc region) facilitates phagocytosis, preventing the pathogen from infecting host cells / neutralising the pathogen
Related
- All IB DP Biology Higher Level (2023 syllabus) revision notes →
- How to answer a "Explain" question →
- Decode the mark scheme abbreviations →
More Defence against disease questions
- Explain how the inflammatory response acts as a non-specific defence mechanism f…
- Explain how clonal selection leads to the production of plasma cells following e…
- Explain how natural killer (NK) cells recognise and destroy virus-infected host …
- Explain how memory cells contribute to a secondary immune response that is faste…